Media Room

VBS Professor Tim Johnson investigates antimicrobial drug-resistant E. coli in Ecuador.

A team of researchers at the University of Minnesota College of Veterinary Medicine (CVM) led by Molly McCue, DVM, MS, PhD, DACVIM, associate dean for research and professor in the Department of Veterinary Population Medicine at the CVM, recently received nearly $60,000 from the Morris Animal Foundation to investigate the genetic risks for equine pituitary pars intermedia dysfunction (PPID).

A team of University of Minnesota researchers led by Jessica Lawrence, DVM, DACVIM, DACVR, DECVDI, and Daniel Vallera, PhD, recently received $500,000 from the V Foundation for Cancer Research to investigate the B7-H3 protein’s role in the immune response in canine and human cancer.

A new Summer 2021 Course, (PUBH 7230), The Biology and Ecology of Infectious Prions, will be taught by VBS Assistant Professor, Peter Larsen.

A team of researchers led by Peter Larsen, PhD, and Davis Seelig, DVM, PhD, DACVP, recently received $225,000 from the Rapid Agricultural Response Fund at the Minnesota Agricultural Experiment Station to determine the chronic wasting disease (CWD) prion burden, and its infectivity, in venison meat and on meat processing equipment.

VBS Professor Tim Johnson discusses the evolution of High-Risk E. coli.

As another touchpoint in a lasting relationship between the University of Minnesota College of Veterinary Medicine (CVM) and the Grand Portage Band of Lake Superior Ojibwe, a team of CVM researchers led by Tiffany Wolf, DVM, PhD, recently received more than $70,000 from project led by Seth Moore, PhD, director of biology and environment at the Grand Portage Band, to continue assisting the tribal nation in investigating moose habitat and population health in a changing climate.

In the United States, approximately 12,000 patients present with glioblastoma, a very aggressive brain or spinal cord cancer, each year.

A live recombinant Pichinde virus (PICV) vector vaccine is safe and effective against turkey arthritis reovirus (TARV), according to a recent study led by Sunil Mor, BVSc & AH, MVSc, PhD, and Hinh Ly, PhD. Vaccination may be an effective way to reduce lameness induced by TARV in flocks, but there are currently no commercial TARV vaccines available.

Mild gastrointestinal erosions are more common in dogs treated with anti-inflammatory medications (NSAIDs) over a long period of time than in control dogs with chronic gastrointestinal (GI) disease, according to a recent study led by Tracy Hill, DVM, DACVIM, PhD, DECVIM.